CRL
Click for more information
0.00% 2.0¢ comet resources limited

If the proposal for mmm were to be rejected in its current form...

  1. Bpharma
    3,977 Posts.
    lightbulb Created with Sketch. 463
    clock Created with Sketch.
    05/04/22
    01:07
    Post #: 60645779
    If the proposal for mmm were to be rejected in its current form crl would look to sell the 25% strategic stake to lower the share issuance dilution to meet the financing needs of the deal
    thats a second worse result
    CRL Price at posting: 2.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

SBW The home PC changed retail stores forever. Shekel Brainweigh can do it again
right-arrow Created with Sketch.
RCE Recce Pharma heading closer to full efficacy data for flagship R327
right-arrow Created with Sketch.
ENR Encounter pulls a rabbit out of the hat chasing copper at Sandover
right-arrow Created with Sketch.
MTL After long delays, Mantle Minerals kicks off drillrun for gold at Mt Berghaus
right-arrow Created with Sketch.
TLG Talga ups graphite exploration target as crit minerals stay in focus
right-arrow Created with Sketch.
RDN Raiden inches closer to Andover South drilling as heritage report clears land
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add CRL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.